Tips for Gut Health Introduction Starting a weight loss journey with GLP-1 medications can feel like a major turning point, but it often comes with a learning curve for your digestive system
ACMSD inhibition has been found to protect against acute kidney injury and NAFLD by increasing NAD + levels in a tissue-specific manner
With its dual-peptide structure, practical vial format, and broad research relevance, BB10 peptide remains a popular choice for advanced laboratory peptide studies
During your consultation, the dermatologist will ask questions about your medical history, lifestyle habits, and diet
When used in patients experiencing lower GI symptoms while taking GLP-1 medications, ARM allows clinicians to: Differentiate between drug-related motility effects and true pelvic floor dysfunction Quantify the severity of anorectal dysfunction to support diagnosis and treatment planning Establish a baseline prior to initiating biofeedback or behavioral therapy Monitor progress if conservative management is pursued Persistent Constipation in GLP-1 Users ARM can determine if dyssynergic defecation is contributing to delayed evacuation, guiding appropriate therapy beyond simply adjusting medication